How do you approach CLL in a patient not currently on treatment who has a solid tumor that requires treatment?   

Do you worry about their marrow reserve and response to neulasta in terms of lymphocytosis and decreased ANC response?



Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Academic Institution